Cellectar Biosciences Inc...

NASDAQ: CLRB · Real-Time Price · USD
4.86
0.37 (8.24%)
At close: Aug 22, 2025, 3:59 PM
4.89
0.62%
After-hours: Aug 22, 2025, 06:28 PM EDT

Cellectar Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-6.04M -6.4M -12.74M -13.33M -13.7M -12M -12.55M -9.41M -8.29M -8.71M -7.42M -7.82M -7.44M -6.14M -5.92M -5.82M -6.03M -6.36M
Interest Income
88.02K 136.96K 244.21K 317.89K 328.91K 319.85K 139.22K 51.11K 72.78K 124.03K 147.44K 4.16K 481.00 430.00 n/a 590.00 659.00 2.36K
Pretax Income
-5.45M -6.6M -2.29M -14.66M -919.37K -26.64M -7.94M -17.52M -10.18M -7.19M -12.47M -7.81M -7.44M -6.14M -5.92M -5.82M -6.03M -6.36M
Net Income
-5.45M -6.6M -2.36M -14.66M -919.37K -26.64M -7.88M -17.52M -10.18M -7.19M -12.41M -7.81M -7.44M -6.14M -5.92M -5.82M -6.03M -6.36M
Selling & General & Admin
3.65M 2.97M 6.54M 7.83M 6.36M 4.91M 4.61M 2.38M 2.16M 2.35M 1.97M 2.44M 2.94M 2.25M 1.54M 1.88M 1.4M 1.73M
Research & Development
2.39M 3.43M 6.21M 5.49M 7.35M 7.09M 7.94M 7.03M 6.14M 6.36M 5.45M 5.38M 4.5M 3.89M 4.39M 3.94M 4.63M 4.63M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
6.04M 6.4M 12.74M 13.33M 13.7M 12M 12.55M 9.41M 8.29M 8.71M 7.42M 7.82M 7.44M 6.14M 5.92M 5.82M 6.03M 6.36M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
6.04M 6.4M 12.74M 13.33M 13.7M 12M 12.55M 9.41M 8.29M 8.71M 7.42M 7.82M 7.44M 6.14M 5.92M 5.82M 6.03M 6.36M
Income Tax Expense
n/a n/a 66K n/a n/a n/a -60K n/a n/a n/a -60K n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
1.61M 1.54M 1.54M 1.31M 1.19M 978.22K 647.37K 376.96K 375.37K 375.37K 310.2K 203.67K 20.37K 203.67K 203.67K 199.56K 175.88K 160.46K
Shares Outstanding (Diluted)
1.61M 1.54M 1.54M 1.31M 1.25M 978.22K 647.37K 376.96K 375.37K 375.37K 310.2K 203.67K 20.37K 203.67K 203.67K 199.56K 175.88K 160.46K
EPS (Basic)
-3.39 -4.3 -1.53 -11.18 -0.77 -27.24 -12.17 -46.48 -27.12 -19.16 -40 -38.35 -365.05 -30.15 -29.06 -29.16 -34.27 -39.62
EPS (Diluted)
-3.39 -4.3 -1.53 -11.18 -5.43 -27.24 -12.17 -46.48 -27.12 -19.16 -40 -38.35 -365.05 -30.15 -29.06 -29.16 -34.27 -39.62
EBITDA
-5.98M -6.34M -12.68M -13.26M -13.64M -11.91M -12.48M -9.37M -8.26M -8.66M -7.38M -7.78M -7.4M -6.1M -5.88M -5.78M -5.99M -6.32M
EBIT
-6.04M -6.4M -12.74M -13.33M -13.7M -12M -12.55M -9.41M -8.29M -8.71M -7.42M -7.82M -7.44M -6.14M -5.92M -5.82M -6.03M -6.36M
Depreciation & Amortization
55.56K 56.3K 68.57K 68.57K 66.02K 88.49K 69.96K 41.21K 38.65K 42.56K 38.16K 32.96K 33.9K 43.42K 39.29K 36.79K 38.7K 35.13K